Combination lipid-lowering therapy as first-line strategy in very high-risk patients

Combination lipid-lowering therapy as first line strategy in very high-risk patients. Combination lipid-lowering therapy as first line strategy in very high-risk patients.

Combination lipid-lowering therapy as first-line strategy in very high-risk patients | Litlas